Categories

All Analgesic Analgesic Combination Antianginal Antibiotic Anticancer Anticoagulant Anticonvulsant Antidepressant Antidiabetic Antidiarrheal Antihypertensive Antimalarial Antiparasitic Antiparkinson Antiplatelet Antipsychotic Anxiolytic Bronchodilator Cardiovascular Corticosteroid Diuretic Emergency Endocrine Gastrointestinal Immunomodulator Immunosuppressant Minerals Neurological NSAID Oncology – Targeted therapy Psychiatric Sedative/Hypnotic Sympathomimetic Vitamins

Antidiabetic Class

Clear
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing 3 drugs starting with: E

Empagliflozin

Brand: Jardiance (US/EU) / Empa (IN) / Empaglo (BD)
Class: Antidiabetic
Subclass: SGLT2 inhibitor
PK: t½ 12 hours | Clearance: mixed
Max Dose: 25 day
moderate
AE: Genital mycotic infections, polyuria, volume depletion, rare euglycemic DKA

Ertugliflozin

Brand: Steglatro (US/EU)
Class: Antidiabetic
Subclass: SGLT2 inhibitor
PK: t½ 17 hours | Clearance: mixed
Max Dose: 15 day
moderate
AE: Genital infections, polyuria, dehydration, euglycemic DKA (rare)

Exenatide

Brand: Byetta (BID) / Bydureon (weekly ER)
Class: Antidiabetic
Subclass: GLP-1 receptor agonist
PK: t½ 2.4 hours | Clearance: renal
Max Dose: 20 day
moderate
AE: Nausea, vomiting, diarrhea, headache; injection-site reactions (ER)